Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://orlandohgdq615696.bloggin-ads.com/62052939/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide